Author(s): Cruz, Andrea ; Fernandes, Elisabete ; Rodrigues, Raquel Oliveira ; Catarino, Susana Oliveira ; Pinho, Diana
Date: 2023
Persistent ID: https://hdl.handle.net/1822/88653
Origin: RepositóriUM - Universidade do Minho
Subject(s): Lab-on-chip; Microfluidic devices; Miniaturization; Organ-on-chip; Detection systems; Drug-device; Digital pills
[Excerpt] Introduction Miniaturization has played a pivotal role in driving innovation in microfluidic devices, particularly in their application across advanced technologies, such as Lab-on-chip platforms, Point-of-care systems, Organ-, Body- and Disease-on-a-chip technology. The personalized nature inherent in these systems, coupled with physiologically relevant readouts, opens novel avenues for individualized disease diagnostics, Figure 1. Additionally, they offer personalized strategies for assessing treatment efficacy and safety. Furthermore, the advancement in micro- and nano-microfluidic fabrication allows parallel analysis of large samples sets and the evaluation of different parameters such as biological molecules, cells or drugs.[...]
